Yes, corneal crosslinking (CXL) is an FDA-approved treatment for progressive keratoconus. It is designed to strengthen the cornea by creating new cross-links between the corneal molecules, which helps to stabilize the cornea and prevent further thinning and bulging. It is a minimally invasive outpatient procedure that has been shown to halt the progression of keratoconus and reduce the need for more invasive procedures like corneal transplants. At Waite Vision, we offer a proven corneal crosslinking method to help manage keratoconus and preserve your vision.